KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |
| Eventide Asset Management | 580,000 | $18,490,400 | 0.33% |
| Woodline Partners LP | 718,423 | $22,903,325 | 0.27% |
| Birchview Capital, LP | 7,000 | $223,160 | 0.19% |
| Candriam S.C.A. | 741,061 | $23,625,024 | 0.17% |
| AMERICAN FINANCIAL GROUP INC | 10,105 | $322 | 0.11% |
| Alkeon Capital Management | 1,676,522 | $53,447,522 | 0.10% |
| Virtus ETF Advisers LLC | 2,561 | $81,645 | 0.05% |
| UBS OCONNOR LLC | 60,341 | $1,923,671 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 17,161 | $547 | 0.05% |
| Chescapmanager LLC | 10,105 | $322,147 | 0.04% |
External links
This page lists KEROS THERAPEUTICS INC's shareholders in Q3 2023. To view KEROS THERAPEUTICS INC's shareholder history, click here.